foxo4-dri senolytic peptide study 2017

foxo4-dri senolytic peptide study 2017 10mg Peptide inhibitors targeting FOXO4-p53 interactions

Name: foxo4-dri senolytic peptide study 2017 10mg Peptide inhibitors targeting FOXO4-p53 interactions
Brand: cantondelareina.com.ar
SKU: 60339317140
Price: 20.87 USD
Availability: InStock
Rating: 4.2547 (29 reviews)

Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell

SKU: 60339317140 · From cantondelareina.com.ar

4.3

USD20.87 USD41.87

Pay in 4 interest-free payments of $5.22 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

The introduction of wortmannin was found to significantly reverse the expression of PI3K and AKT, as well as the anti-apoptotic and anti-inflammatory effects of Dihexa, resulting in a decrease in the number of neuronal cells present in the cortex and the levels of IL-10, and an increase in the levels of TNF-alpha and IL-1-beta [1]

(19,20) What is TB-500

Moreover, data are more abundant for the peripheral expression and function of these transporters, and less is known about the BBB, with the exception perhaps of the P-gp